EP Patent

EP4294367A4 — NON-AQUEOUS INJECTABLE COMPOSITION FOR THE SUSTAINED RELEASE OF BUPRENORPHINE AND USE THEREOF

Assigned to Navin Saxena Research and Technology Pvt Ltd · Expires 2025-02-12 · 1y expired

What this patent protects

Patent listed against Subutex.

Drugs covered by this patent

Patent Metadata

Patent number
EP4294367A4
Jurisdiction
EP
Classification
—
Expires
2025-02-12
Drug substance claim
No
Drug product claim
No
Assignee
Navin Saxena Research and Technology Pvt Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.